Synergistic Cytotoxic Effects of Bortezomib and CK2 Inhibitor CX-4945 in Acute LymphOblastic Leukemia: Turning Off the Prosurvival ER Chaperone BIP/Grp78 and Turning on the Pro-apoptotic NF-κB

Thumbnail
View/ Open

Show full item record
Author
McCubrey, James A.
URI
http://hdl.handle.net/10342/9588
Date
2016-01-12
Citation:
APA:
McCubrey, James A.. (January 2016). Synergistic Cytotoxic Effects of Bortezomib and CK2 Inhibitor CX-4945 in Acute LymphOblastic Leukemia: Turning Off the Prosurvival ER Chaperone BIP/Grp78 and Turning on the Pro-apoptotic NF-κB. , (), - . Retrieved from http://hdl.handle.net/10342/9588

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A.. "Synergistic Cytotoxic Effects of Bortezomib and CK2 Inhibitor CX-4945 in Acute LymphOblastic Leukemia: Turning Off the Prosurvival ER Chaperone BIP/Grp78 and Turning on the Pro-apoptotic NF-κB". . . (), January 2016. January 31, 2023. http://hdl.handle.net/10342/9588.
Chicago:
McCubrey, James A., "Synergistic Cytotoxic Effects of Bortezomib and CK2 Inhibitor CX-4945 in Acute LymphOblastic Leukemia: Turning Off the Prosurvival ER Chaperone BIP/Grp78 and Turning on the Pro-apoptotic NF-κB," , no. (January 2016), http://hdl.handle.net/10342/9588 (accessed January 31, 2023).
AMA:
McCubrey, James A.. Synergistic Cytotoxic Effects of Bortezomib and CK2 Inhibitor CX-4945 in Acute LymphOblastic Leukemia: Turning Off the Prosurvival ER Chaperone BIP/Grp78 and Turning on the Pro-apoptotic NF-κB. . January 2016; (): . http://hdl.handle.net/10342/9588. Accessed January 31, 2023.
Collections